Children's National Hospital
Washington D.C., District of Columbia, 20010, United States
NCT Number: NCT06938542
The palliative care needs of family caregivers of children with rare diseases and their children are largely unmet, including the need for support to prepare for future medical decision making. This trial will test the FACE-Rare intervention to see if investigators can identify and meet those needs; and if FACE-Rare effects family caregivers' quality of life and child healthcare utilization. Finally, investigators will determine if the intersectionality of child-sex, family-race, Federal poverty level, and social connection influences family quality of life and child health care utilization longitudinally.
Interested in participating?
Request Info12 month–99 year
All sexes
Interventional
Not applicable
Washington D.C., District of Columbia, 20010, United States
Pediatric patients with rare diseases experience high mortality with 30% not living to see their 5th birthday. Families are likely to be asked to make complex medical decisions for their child. Pediatric advance care planning involves preparation and skill development to help make future medical care choices. Children with rare disorders are a heterogeneous group, resulting in their exclusion from research. Available research on families of children with rare diseases lacks scientific rigor. Although desperately needed, there are few empirically validated interventions to address these issues. Investigators propose to close a gap in our knowledge of families' needs for support in a heterogeneous group of children with rare diseases; and to test an advance care planning intervention. The FAmily CEntered (FACE) pediatric advance care planning intervention is adapted to families with children who have rare diseases. Theoretically informed and developed and adapted by the principal investigator and key stakeholders, the proposed intervention will use Respecting Choices Next Steps Pediatric ACP™ for families whose child is unable to participate in health care decision-making. Our consultation with families of children with rare disorders and the National Organization for Rare Disorders (NORD) revealed that basic palliative care needs should be addressed first, prior to an advance care planning intervention. For the study to be able to meet this request, all families randomized to the intervention will first complete the Carer Support Needs Assessment Tool (CSNAT)© adapted by investigators for use in pediatrics. In the CSNAT Approach, facilitators assess caregivers' prioritized palliative care needs and develop Shared Action Plans for increasing informal social support. Thus, investigators propose an innovative 3-session FACE-Rare intervention, integrating two evidence-based approaches. Investigators will evaluate FACE-Rare using a scientifically rigorous intent-to-treat, assessor-blinded, longitudinal, prospective, three-site, randomized controlled trial design. Family/child triads (N=160) will be randomized to FACE-Rare (CSNAT Sessions 1 & 2 plus Respecting Choices Sessions 3) or an enhanced information Treatment as Usual control group. All families will complete questionnaires at baseline and follow-up at 3-, 6- and 12 months. Investigators will evaluate the effect of FACE-Rare on family quality of life (caregiver appraisal, psychological, spiritual). Investigators will assess the palliative care needs of families at four time points. Investigators will determine the intersectionality of child-sex, family-race, and household income on family caregiver quality of life and child healthcare utilization. Investigators will explore the influence of urban vs. rural setting and religious coping on quality-of-life outcomes. Investigators will use advanced statistical methods informed by statistical advice from rare disease investigators for clinical trials in small populations.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Child inclusion criteria:
Family caregiver inclusion criteria:
Support person inclusion criteria:
Exclusion criteria
Child with rare disease who is unable to participate in medical decision making/family caregiver/support person triads will be randomized at a 1:1 ratio to one of two study arms, either the 3 session FACE-Rare intervention or the enhanced Treatment as Usual. Assessments will be completed at baseline, 3, 6 and 12 month outcomes.
Time frame: Baseline, 3-, 6-, and 12 month post-intervention
The FACQ-PC is a 25-item measure consists of four theoretically derived subscales: (i) caregiver strain, (ii) positive caregiving appraisals, (iii) caregiver distress, and (iv) family well-being. Scores are from 5 = strongly agree to 1 = strongly disagree. Investigators will not calculate a Total score. On the subscale scores for positive caregiving appraisals and family well-being, higher scores mean better outcomes, i.e. greater positive caregiving appraisals or family well-being. On the subscale scores for caregiver strain and caregiver distress, higher scores mean worse outcomes, i.e. greater caregiver strain or caregiver distress. The FACQ-PC subscale scores will be computed by taking the mean of the items (score range 1-5). Some items are reverse scored, depending on how the item is phrased, so that higher scores = higher amount of the subscale being measured. So the minimum value for each subscale is 1 and the maximum value for each subscale is 5.
Time frame: Baseline, 3-, 6-, and 12 month post-intervention
Assessed construct of spiritual well-being. Two subscales Meaning/Peace (7 items) and Faith (5 items) and Total score (12 items) were calculated. on a 5-point Likert scale from 0=not at all to 5=very much. Some items are reverse scored. See www.facit.org Meaning/Peace subscale score range from minimum value of 0 to maximum value of 32. Higher scores indicate better meaning/peace.
Faith subscale score range from 0 minimum value to maximum value of 16. Higher scores indicate better meaning/peace.
Total score range is from 0 minimum value to maximum value of 92. Higher scores indicate better spiritual well-being.
Time frame: Baseline and 1 year
Documentation of an advance care plan for child with rare disease in the Electronic Health Record and decisional preference - to continue all treatments, to continue all treatments with exceptions noted, to provide comfort care only.
Time frame: Baseline, 3-, 6-, 12-month.
Using a standardized data abstraction form to count initiation of palliative care consultations during the study.
Time frame: Baseline, 3-, 6-, 12-month
Quality of life indicator with respect to emotional health-anxiety symptoms. 7 items. Higher scores indicate greater anxiety.
Time frame: Baseline, 3-, 6-, 12-month
Quality of life indicator with respect to emotional health-depressive symptoms. 9 items. Higer scores indicate higher symptoms of depression. A yes response to question 9 (self-harm) will trigger a referral.
Time frame: Baseline, 3-, 6-, 12-month
Using a standardized data abstraction form to count # of days in palliative care before death.
Time frame: Baseline, 3-, 6-, 12-month
Using a standardized data abstraction form to count # of days hospitalized during the study.
Time frame: Baseline, 3-, 6-, 12-month
Using a standardized data abstraction form to count # of days used Emergency Department during study.
Time frame: Baseline, 3-, 6-, 12-month
Using a standardized data abstraction form to count # of days was admitted to ICU during the study.
Time frame: Baseline, 3-, 6-, 12-month
Using a standardized data abstraction form to count # of surgeries during the study.
Time frame: Baseline
Age of family caregiver, support person, and child.
Time frame: Week 4
Study specific process measure to assess adverse events and benefit/burden of participation. 13 items. Higher scores indicate greater satisfaction. Items are on a 5-point Likert scale from strongly disagree to strongly agree. 6 items were negative (felt afraid, too much to handle, harmful, angry, sad, hurtful) and 7 items were positive (useful, helpful, load off my mind, satisfied, something I needed to do, courageous, worthwhile). Each subscale is scored separately. Higher score for positive scale was better outcome. Higher score for negative scale was worse outcome.
Time frame: Baseline, 3-, 6-, 12-month
Visual analogue scale 0-100. "How stressful is it for you to make medical decisions for your child?" 1 item.
Time frame: Baseline, 3-, 6-, 12-month
Responses to 5 items from our previous research will be used to test moderator effects: "How often do you go to religious services? How often do you feel God's presence? how often do you pray privately? Do you identify as a religious person? Do you identify as a spiritual person?" Responses are on a 5 point likert scale. Higher scores indicated greater attendance at religious services, etc.
Time frame: Baseline, 3-, 6-, 12-month
NINR/National Institute of Health: "The SDOH are the conditions in which people are born, grow, live, work and age…." 32 items. Social connection score (how often, talk on telephone with family, friends, neighbors; get together; attend church or religious services; belong to clubs or organizations; marital partner status) and 2023 Federal Poverty Level for household income. Health insurance and housing insecurity will be used in secondary analysis.
Time frame: Baseline, 3-, 6-, 12-month
Urban vs. rural setting. Address of participant is entered into the online analyzer, and it determines if this is a rural or urban setting which will be recorded in the data base.
Time frame: Sessions 1 and 2 -- 2 and 3-4 weeks post baseline
Measures child and family caregiver palliative care needs: The CAT is an evidence-based, comprehensive tool comprising 12 questions (broad areas of support need), used to identify two domains of unmet support needs, the current caring situation and the health and well-being of the caregiver. There is a traffic light scoring system so caregivers can rate their support need as green (low), amber (medium), and red (high) indicating level of need and potential risk each alert poses to the caregiving situation. Administered only to intervention participants.
Time frame: Baseline.
Sex of child, family caregiver and support person.
Time frame: Baseline.
Race of child, family caregiver, and support person
Time frame: Baseline.
Ethnicity of child, family caregiver, and support person.
Time frame: Baseline.
Marital status of family caregiver and support person.
Time frame: Baseline.
Education of family caregiver and support person.
Time frame: Baseline.
Income above or below the 2025 Federal Poverty Level. Number of persons living in the household and household income will be collected to calculate these data.
Children's National Research Institute
Other
Acronym: FACE-Rare
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06740162
Abnormalities, Multiple, Aniridia
Fayetteville, Arkansas, United States
View Trial DetailsNCT01793168
1p36 Deletion Syndrome, 3-Methylglutaconic Aciduria, Type V
Sioux Falls, South Dakota, United States
View Trial DetailsNCT04463316
17p- Deletiesyndrome, 1q25-32 Deletie
Rotterdam, South Holland, Netherlands
View Trial DetailsNCT04429750
Congenital Abnormalities, Congenital Diaphragmatic Hernia
Amiens, France
View Trial Details